PHASE Diagnostics

PHASE Diagnostics is a diagnostics technology company specializing in rapid and at-home testing solutions powered by proprietary PHASIFY™ technology. The company develops innovative diagnostic offerings focused on early detection and prevention, with particular emphasis on cancer and infectious disease screening. PHASE offers three primary product lines: INDICAID rapid tests for point-of-care use, INDICAID lab at-home laboratory tests, and PHASE lab medical testing services. The PHASIFY™ technology platform enables rapid detection of target molecules, supporting urine-based and other non-invasive screening methods including HPV cervical cancer screening and respiratory pathogen detection. The company holds FDA CLIA waiver status and conducts clinical studies to validate diagnostic accuracy. PHASE positions itself at the intersection of preventive healthcare and diagnostic innovation, targeting both consumer self-testing and clinical laboratory markets.